Annual Current Assets
$14.93 M
+$1.23 M+8.99%
31 December 2023
Summary:
Eupraxia Pharmaceuticals Common Stock annual total current assets is currently $14.93 million, with the most recent change of +$1.23 million (+8.99%) on 31 December 2023. During the last 3 years, it has risen by +$14.04 million (+1572.38%). EPRX annual current assets is now -37.80% below its all-time high of $24.00 million, reached on 01 December 2021.EPRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$9.89 M
-$14.64 M-59.67%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock quarterly total current assets is currently $9.89 million, with the most recent change of -$14.64 million (-59.67%) on 01 September 2024. Over the past year, it has dropped by -$14.96 million (-60.19%). EPRX quarterly current assets is now -72.69% below its all-time high of $36.22 million, reached on 31 March 2024.EPRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.0% | -60.2% |
| 3 y3 years | +1572.4% | -63.1% |
| 5 y5 years | +721.9% | - |
EPRX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.8% | +1572.4% | -72.7% | at low |
| 5 y | 5 years | -37.8% | +1572.4% | -72.7% | +2170.4% |
| alltime | all time | -37.8% | +1572.4% | -72.7% | +2170.4% |
Eupraxia Pharmaceuticals Common Stock Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.89 M(-59.7%) |
| June 2024 | - | $24.53 M(-32.3%) |
| Mar 2024 | - | $36.22 M(+82.9%) |
| Dec 2023 | $349.10 K(-11.1%) | $19.80 M(-20.3%) |
| Sept 2023 | - | $24.85 M(+66.8%) |
| June 2023 | - | $14.89 M(-19.9%) |
| Dec 2022 | $392.90 K | - |
| Dec 2022 | - | $18.59 M(-17.4%) |
| Sept 2022 | - | $22.51 M(-20.3%) |
| June 2022 | - | $28.25 M(+32.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $21.34 M(-11.1%) |
| Dec 2021 | $486.60 K(+96.8%) | $24.00 M(-10.6%) |
| Sept 2021 | - | $26.84 M(-9.7%) |
| June 2021 | - | $29.73 M(+16.3%) |
| Mar 2021 | - | $25.56 M(+2763.3%) |
| Dec 2020 | $247.30 K(-50.0%) | $892.60 K(+104.9%) |
| Sept 2020 | - | $435.60 K(-78.4%) |
| Dec 2019 | $494.70 K(+54.7%) | $2.02 M |
| Dec 2018 | $319.70 K(-4.2%) | - |
| Dec 2017 | $333.60 K | - |
FAQ
- What is Eupraxia Pharmaceuticals Common Stock annual total current assets?
- What is the all time high annual current assets for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock annual current assets year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock quarterly total current assets?
- What is the all time high quarterly current assets for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock quarterly current assets year-on-year change?
What is Eupraxia Pharmaceuticals Common Stock annual total current assets?
The current annual current assets of EPRX is $14.93 M
What is the all time high annual current assets for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high annual total current assets is $24.00 M
What is Eupraxia Pharmaceuticals Common Stock annual current assets year-on-year change?
Over the past year, EPRX annual total current assets has changed by +$1.23 M (+8.99%)
What is Eupraxia Pharmaceuticals Common Stock quarterly total current assets?
The current quarterly current assets of EPRX is $9.89 M
What is the all time high quarterly current assets for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high quarterly total current assets is $36.22 M
What is Eupraxia Pharmaceuticals Common Stock quarterly current assets year-on-year change?
Over the past year, EPRX quarterly total current assets has changed by -$14.96 M (-60.19%)